Register entry

Amryt Pharmaceuticals DAC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
capsule2
gel1
RouteNDCs
oral2
topical1
Labeller name on the listingNDCs
amryt pharmaceuticals dac3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
FILSUVEZbirch triterpenesgel, topical76431-310NDA
Juxtapidlomitapide mesylatecapsule, oral76431-110NDA
Juxtapidlomitapide mesylatecapsule, oral76431-120NDA
Compare

Other companies listing lomitapide mesylate

Enquiry

Common questions

Is Amryt Pharmaceuticals DAC FDA approved?
Amryt Pharmaceuticals DAC holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Amryt Pharmaceuticals DAC make?
3 products are listed under Amryt Pharmaceuticals DAC in the openFDA NDC Directory, most often as capsule; gel. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.